Federated Hermes
HRMY icon

Federated Hermes’s Harmony Biosciences HRMY Stock Holding History

Federated Hermes’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.82M Buy
279,130
+15,287
+6% +$501K 0.01% 706
2025
Q4 		$9.87M Sell
263,843
-34,393
-12% -$1.13M 0.02% 617
2025
Q3 		$8.22M Buy
298,236
+4,394
+1% +$151K 0.01% 610
2025
Q2 		$9.29M Sell
293,842
-146,042
-33% -$4.7M 0.02% 588
2025
Q1 		$14.6M Sell
439,884
-52,919
-11% -$1.9M 0.03% 471
2024
Q4 		$17M Sell
492,803
-49,276
-9% -$1.69M 0.04% 444
2024
Q3 		$21.7M Buy
542,079
+16,555
+3% +$581K 0.05% 405
2024
Q2 		$15.9M Sell
525,524
-17
-0% -$511 0.04% 447
2024
Q1 		$17.6M Buy
525,541
+204
+0% +$6.55K 0.04% 441
2023
Q4 		$17M Buy
525,337
+501,809
+2,133% +$14M 0.04% 426
2023
Q3 		$771K Buy
23,528
+355
+2% +$12.3K ﹤0.01% 1208
2023
Q2 		$815K Sell
23,173
-15,363
-40% -$530K ﹤0.01% 1204
2023
Q1 		$1.26M Buy
38,536
+9,013
+31% +$410K ﹤0.01% 1097
2022
Q4 		$1.63M Buy
29,523
+2,242
+8% +$123K ﹤0.01% 978
2022
Q3 		$1.21M Sell
27,281
-12,120
-31% -$591K ﹤0.01% 1061
2022
Q2 		$1.92M Buy
39,401
+11,146
+39% +$502K 0.01% 941
2022
Q1 		$1.38M Buy
+28,255
New +$1.15M ﹤0.01% 1137

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Federated Hermes's HRMY Position: Q1 2026 in Review

Federated Hermes increased its Harmony Biosciences (HRMY) stake by 5.8% in Q1 2026, buying an estimated $501K and bringing the position to 279,130 shares worth $7.82M. The position accounts for 0.01% of the portfolio, ranked #706.

Federated Hermes first reported a position in HRMY in Q1 2022 and has held it in 17 quarters since. The position peaked at $21.7M in Q3 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Federated Hermes held 279,130 shares of Harmony Biosciences worth $7.82M as of Q1 2026.
  • Federated Hermes bought 15,287 Harmony Biosciences shares in Q1 2026, an estimated $501K.
  • Harmony Biosciences made up 0.01% of Federated Hermes's portfolio in Q1 2026, its #706 holding.
  • Federated Hermes first reported a position in Harmony Biosciences in Q1 2022 and has held it in 17 quarters since.
  • Federated Hermes's Harmony Biosciences position peaked at $21.7M in Q3 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.